The power of clinical genomics in cancer diagnosis and treatment
Clinical genomics is a swiftly evolving field that merges genomic data with clinical insights to enhance patient care, diagnosis, and treatment strategies.
FAQs on Gallbladder Cancer
India has one of the highest incidence of GB cancer, an otherwise rare cancer elsewhere in the world. It is estimated that India contributes to ~10% of the global GBC burden. Read this blog to know more about this cancer and on how genomics can help in prevention of GBC.
Democratising cancer prevention with germline testing
Genomics, the study of an individual’s genes and their interactions, play a pivotal role in identifying and understanding hereditary cancer risks. This article explores the benefits of genetic testing and how it is important in cancer prevention.
Can pre-emptive germline testing and genomics help resolve challenges in cervical cancer?
Evidence from across the world suggests around 10% of patients with cancer have a germline or hereditary genetic variant, which make them predisposed to developing cancer. Understanding the gene and variant could have implications in screening additional members in the family. Know more
Pink Ribbon in my hand: Empowering the fight with strong defense strategies
The pink ribbon serves as a global symbol of breast cancer awareness, fostering a sense of unity and solidarity. It reminds us that every patient was once just a storyteller of suffering. Understanding the experiences of others increases the awareness of when to seek medical assistance.
Karkinos Healthcare establishes India’s first oncology laboratory for comprehensive cancer diagnostic services
The diagnostic centers will leverage capabilities and spearhead the cancer care delivery with robust, evidence-based and data-supported protocols bringing in a generational shift in the way cancer care is delivered in India.
C2i Genomics and Karkinos Healthcare Partner to Bring AI-Powered Cancer Detection and Monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
